Metronidazole, acyclovir and tetrahydrobiopterin may be promising to treat COVID-19 patients, through interaction with interleukin-12

B Farasati Far, D Bokov, G Widjaja… - Journal of …, 2023 - Taylor & Francis
COVID-19 patients have shown overexpressed serum levels of several pro-inflammatory
cytokines, leading to a high mortality rate due to numerous complications. Also, previous …
被引用次数：11 相关文章

Metronidazole, acyclovir and tetrahydrobiopterin may be promising to treat COVID-19 patients, through interaction with interleukin-12

BF Far, D Bokov, G Widjaja, HS Budi… - Journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
COVID-19 patients have shown overexpressed serum levels of several pro-inflammatory
cytokines, leading to a high mortality rate due to numerous complications. Also, previous …

Metronidazole, acyclovir and tetrahydrobiopterin may be promising to treat COVID-19 patients, through interaction with interleukin-12.

BF Far, D Bokov, G Widjaja, HS Budi, WK Abdelbasset… - 2023 - cabidigitallibrary.org
COVID-19 patients have shown overexpressed serum levels of several pro-inflammatory
cytokines, leading to a high mortality rate due to numerous complications. Also, previous …

Metronidazole, acyclovir and tetrahydrobiopterin may be promising to treat COVID-19 patients, through interaction with interleukin-12

BF Far, D Bokov, G Widjaja, HS Budi… - Journal of …, 2023 - scholar.unair.ac.id
COVID-19 patients have shown overexpressed serum levels of several pro-inflammatory
cytokines, leading to a high mortality rate due to numerous complications. Also, previous …

Metronidazole, acyclovir and tetrahydrobiopterin may be promising to treat COVID-19 patients, through interaction with interleukin-12.

D Bokov, G Widjaja, S Javanshir, F Seif… - … Structure & Dynamics, 2022 - europepmc.org
COVID-19 patients have shown overexpressed serum levels of several pro-inflammatory
cytokines, leading to a high mortality rate due to numerous complications. Also, previous …

Metronidazole, acyclovir and tetrahydrobiopterin may be promising to treat COVID-19 patients, through interaction with interleukin-12

B Farasati Far, D Bokov, G Widjaja… - Journal of …, 2023 - ingentaconnect.com
COVID-19 patients have shown overexpressed serum levels of several pro-inflammatory
cytokines, leading to a high mortality rate due to numerous complications. Also, previous …